Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM
Salesforce shares fell 1.6% to $235.78 late Thursday morning, underperforming gains in major U.S. stock indexes. Wolfe Research reiterated an Outperform rating and $350 price target after Salesforce’s Agentforce World Tour in Boston. Salesforce is rolling out new AI features in Slack and announced a health care software win with Spain’s Adamed Laboratorios. The stock is still recovering from a 6.5% drop earlier in the week.